Fig. 7
From: TPX2 promotes papillary renal cell carcinoma progression by forming a ceRNA with LINC00894
TPX2 as a Prognostic Marker in Type 2 pRCC. A Immunohistochemical staining of TPX2 in adjacent normal and tumor tissues. B Kaplan–Meier survival analysis showing the correlation between TPX2 expression and overall survival (OS) in type 2 pRCC patients. C Schematic diagram of the LINC00894/miR-660-5p/TPX2 regulatory axis, created using BioRender. Statistical significance is denoted as *p < 0.05, **p < 0.01, and ***p < 0.001